Tech Company Financing Transactions
Samabriva Funding Round
Samabriva, based in Amiens, raised $4.4 million in funding from InvestSud and Noshaq.
Transaction Overview
Company Name
Announced On
12/12/2023
Transaction Type
Venture Equity
Amount
$4,400,000
Round
Undisclosed
Proceeds Purpose
The funding will increase the speed with which Samabriva's technology is deployed and ensure the transformation of the company into a fully-fledged CDMO.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
72 rue des Jacobins
Amiens, 80 000
FR
Amiens, 80 000
FR
Phone
Website
Email Address
Overview
Samabriva is a plant-based biotechnology company that has successfully developed an automated, proprietary bioproduction system available to companies who want to produce high-value molecules including natural molecules from plants and recombinant proteins. The platform combines the advantages of plant-based systems (low cost, safe, serum- and animal-free) with traditional bioproduction in large-scale bioreactors to offer continuous, reliable and environmentally sustainable manufacture of a wide range of high value molecules all year round, in any location.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Pascal Lizin
Chief Executive Officer
Marina Cuillet
Browse more venture capital transactions:
Prev: 12/12/2023: Freya Biosciences venture capital transaction
Next: 12/12/2023: Aria venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs